売上高・売上総利益率の推移
| 年度 |
売上高 |
売上総利益率 |
| 2022/12 |
2,514 |
- |
| 2020/12 |
312 |
- |
営業利益・営業利益率の推移
| 年度 |
営業利益 |
営業利益率 |
| 2022/12 |
-68,304 |
-2716.9% |
| 2020/12 |
-88,198 |
-28268.6% |
| 2019/12 |
-8,944 |
- |
| 2018/12 |
-11,331 |
- |
| 2017/12 |
-19,031 |
- |
| 2016/12 |
-18,825 |
|
| 2015/12 |
-34,352 |
|
| 2014/12 |
-36,718 |
|
| 2013/12 |
-40,909 |
|
| 2012/12 |
-23,482 |
|
|
(単位:千ドル)
|
2012/12
|
2013/12
|
2014/12
|
2015/12
|
2016/12
|
2017/12
|
2018/12
|
2019/12
|
2020/12
|
2022/12
|
|
売上高
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
312
|
2,514
|
|
研究開発費
|
24,519
|
32,640
|
26,573
|
16,721
|
10,449
|
11,165
|
2,219
|
2,616
|
72,713
|
55,210
|
|
営業費用
|
29,580
|
40,953
|
36,718
|
34,352
|
18,825
|
19,031
|
11,331
|
8,944
|
88,510
|
70,818
|
|
営業利益
|
-23,482
|
-40,909
|
-36,718
|
-34,352
|
-18,825
|
-19,031
|
-11,331
|
-8,944
|
-88,198
|
-68,304
|
|
営業利益率 (%)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-28268.6
|
-2716.9
|
|
純利益
|
-23,509
|
-41,948
|
-37,998
|
-35,378
|
-27,019
|
-21,987
|
-12,004
|
-10,294
|
-89,535
|
-70,730
|
|
純利益率(%)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-28697.1
|
-2813.4
|
|
一株あたり利益
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-0.79
|
|
希薄化後一株あたり利益
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-0.79
|
|
EBITDA
|
|
|
|
|
|
-18,983
|
-11,312
|
-
|
-
|
-
|